Clinical Operations

Clinical trial recruitment payment language ad review checklist

A site and sponsor checklist for reviewing clinical trial recruitment payment and reimbursement language in ads, flyers, landing pages, and referral copy.

Payment and reimbursement language should inform prospective participants without making compensation the headline, implying free treatment, or promising eligibility, enrollment, or study benefit.

In this guide

Key points

  • Recruitment payment language should be accurate, modest, and consistent with approved study materials.
  • Ads can mention payment, but the amount should not dominate the visual hierarchy or become the primary hook.
  • Teams should separate payment language from eligibility, consent, screening, and medical-benefit expectations.

Payment language should not become the campaign

Payment and reimbursement language helps prospective participants understand practical logistics. It should not make compensation the main value proposition or imply an outcome that the study team has not reviewed.

FDA's recruiting guidance says advertisements may state that subjects will be paid, but should not emphasize payment or the amount through larger or bold type. The same guidance cautions against promising free medical treatment when the intent is only that subjects will not be charged for taking part in the investigation.

Put logistics in the right order

A strong ad or landing page usually explains the study topic, general location, broad fit, time or visit commitment, and contact path before payment details. That order helps patients understand the practical decision before they focus on compensation.

Payment language should be specific enough to avoid confusion but not so detailed that the public page becomes the payment policy source of truth. Protocol-specific or site-specific details should stay in the approved study workflow.

Review the copy after inquiries arrive

The review should continue after launch. If patients repeatedly ask about payment before they understand screening or visit expectations, the source may be creating low-context inquiries.

TrialsNest can help teams review source, status, follow-up outcome, and close reason together so payment-heavy copy can be evaluated by movement quality rather than form volume alone.

Illustrative example

Case-style example

A site launches a flyer with a payment amount in the largest type on the page. Inquiries increase, but coordinators hear repeated questions about when payment happens before patients understand screening, visit timing, or eligibility review.

The sponsor reads the campaign as high-performing because form volume rises.

The revised ad moves payment into a smaller logistics section and leads with study topic, location, time commitment, and study-team review.

Operator note

If a source creates many inquiries but coordinators spend the first call correcting payment expectations, the ad did not just create traffic. It created cleanup work.

Common mistakes

Putting compensation in the headline

Large, bold, or headline payment language can make money feel like the main reason to inquire instead of one practical participation detail.

Using vague free-treatment language

Copy should not imply free medical treatment when the intended point is only that participants are not charged for taking part in the investigation.

Before you start

  • Check visual emphasis: Review whether payment, reimbursement, or no-cost wording is larger, bolder, or more prominent than the study purpose and follow-up wording.
  • Check eligibility boundaries: Use language such as may be a fit, study team review, and screening is required instead of wording that implies qualification or enrollment.
  • Check source performance after launch: Compare inquiries, completed prescreens, declined records, payment-related questions, and close reasons before increasing spend on the same copy.
  • Does payment language match the approved study materials?
  • Is the amount visually emphasized more than study purpose, time commitment, location, or contact path?
  • Does the copy explain that screening and study-team review come before participation?
Sources and editorial notes

Published .

Operational recruitment-copy review guidance only. Payment, reimbursement, advertising, IRB, sponsor, and consent requirements should follow the applicable approved study process.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

See TrialsNest in action

Bring this workflow into one place.

Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.

Site clinical operations

Coordinator Today

Your inquiries, priorities, and upcoming visits.

Inquiries assigned
14
3 pending review
Visits today
6
4 in person · 2 virtual
Action priorities
4
Needs attention
Active studies
3
Study A · B · C
Daily priorities

Priority tasks

  • Review screening intakeInquiry 001 · Study A
    Completed
  • Verify specimen preparationStudy A · Due 10:00 AM
    Completed
  • Confirm visit windowInquiry 003 · Follow-up
    Pending
Today’s schedule

Upcoming visits

  1. In personInquiry 001

    Study A · Baseline visit

    View visit details →
  2. TelehealthInquiry 003

    Study A · Prescreen

    Review appointment →
  3. In personInquiry 004

    Study B · Week 4

    View visit details →

Keep reading